Stanford University
Showing 25,351-25,400 of 34,888 Results
-
Fran Riley
Clinical Assistant Professor, Emergency Medicine
BioDr. Fran Riley is a physician engineer and Clinical Assistant Professor at Stanford University. She obtained her undergraduate degree from the University of Waterloo where she focused on robotics. Driven by her passion for merging medicine and technology, she pursued a Master's degree in Computer Science at The Johns Hopkins University, where she developed a motor controller for an early prototypes of the Da Vinci robot for ENT surgical applications. Dr. Riley thesis focused on utilizing real-time monitoring data to enhance the treatment of traumatic brain injuries in the pediatric intensive care unit.
Following her work in robotics and computer science, Dr. Riley transitioned to the healthcare industry, where she served as a product manager at Microsoft. In this role, she lead multidisciplinary teams to develop multiple features for an electronic medical record dedicated to data analytics. The product was then acquired by GE Healthcare.
Dr. Riley then pursued a medical degree at the University of Vermont, followed by a residency and chief residency at Maimonides Medical Center. She then completed a fellowship in emergency ultrasound at Columbia University Medical Center.
At Stanford, Dr. Riley is an integral part of the Stanford Emergency Medicine Partnership Program (STEPP), utilizing her technical expertise to identify industry partners for research collaborations and product development. She also actively contributes to a hospital-wide committee dedicated to evaluating the use of informatics for clinical care, prioritizing patient safety and high-quality care.
Dr. Riley's clinical research focuses on leveraging artificial intelligence in image recognition for regional wall motion abnormalities, specifically utilizing point-of-care ultrasound to diagnose acute coronary syndrome. -
Geoffrey Riley
Clinical Professor, Radiology
Current Research and Scholarly InterestsMSK tumors, sarcomas, bone tumors, soft tissue tumors.
-
Reiko Riley
Director of Education and Program Development, Psychiatry and Behavioral Sciences
Current Role at StanfordSr. Education Program Manager
Member of the Diversity, Equity, and Inclusion Advisory Committee (Psychiatry and Behavioral Sciences) -
Ellen Youngsoo Rim
Assistant Professor of Chemical Engineering
BioPlants are increasingly vulnerable to environmental stressors—such as pathogen infection, drought, and heat—from climate change. These challenges threaten global food security and limit the carbon sequestration potential of plants. Our research goal is to sustainably enhance plant productivity and resilience through protein engineering. We engineer proteins involved in plant immune and hormone signaling pathways using directed evolution in high-throughput single cell systems. Directed evolution is a synthetic biology approach that enables rapid development of proteins with novel or improved functions. We combine this approach with machine learning, which allows us to learn from large datasets generated during the directed evolution process. Engineered proteins are then introduced into plants to enhance crop yields and climate resilience.
-
Brian Ring
Graduate, Stanford Distinguished Careers Institutes
BioDr. Brian Ring received his PhD in molecular biology and genetics from Cornell University and completed his post-doctoral training at Stanford University School of Medicine.
Dr. Ring is an experienced bioinformatics leader with many years in oncology-focused research and diagnostics, including the development of several clinically utilized gene expression-based companion diagnostics. He has also been the CSO and founder of multiple companies operating in the health field.
Currently, Dr. Ring is an affiliate in the school of Medicine - Med/Stanford Prevention Research Center. -
Huijun Ring, Ph.D.
Affiliate, Distinguished Careers Institute
BioDr. Huijun Ring received her PhD in molecular biology and genetics from Cornell University and completed her post-doctoral medical genetics training at Stanford University School of Medicine. She is a clinical molecular geneticist and board-certified by the American Board of Medical Genetics.
Dr. Ring is an experienced biotech entrepreneur and executive. Previously she worked at Incyte Pharmaceuticals and DNA Direct in Silicon Valley. She was the founder and CEO of iDNA Inc, a precision medicine company. iDNA Inc. was named as one of the fastest growing technology companies in China by Deloitte and was acquired by a public company. She has also cofounded and advised several biotech startups in Silicon Valley and mentored many first-time entrepreneurs.
Currently, Dr. Ring works on genomic medicine, AI health and longevity research. She mentors students from the Stanford Graduate School of Business, and junior women faculty in science and medicine through the Stanford University Faculty Development Office. Additionally, Dr. Ring teaches the course MED 272: Science and History of Traditional Chinese Medicine and MED 132: Exploring Chinese Medicine. Dr. Ring is co-founder of Stanford Hub for AI Wellbeing and Longevity. -
Lawrence Rinsky
Professor (Clinical) of Orthopaedic Surgery, Emeritus
Current Research and Scholarly InterestsThe primary subjects of my research interests over the past ten years have been clinical reviews of series of patients with a variety of pediatric orthopaedic treatable conditions. These have included neuromuscular scoliosis, developmental dislocation of the hip, and deformities in cerebral palsy.
-
Eon Joseph Rios, MD, PhD
Clinical Assistant Professor (Affiliated), Dermatology
Staff, DermatologyBioEon Rios, M.D., Ph.D., is a Clinical Assistant Professor (Affiliated) of Dermatology at Stanford University and Attending Physician at Santa Clara Valley Medical Center. His research interests span basic science investigations studying non-coding regulators of epidermal differentiation to investigations of the skin and gut Microbiome in dermatology patients. Clinically he is interested in general and complex medical dermatology.
-
Sonia Rios-Ventura
Family Health Navigator, Medicine - Med/Oncology
BioSonia Rios-Ventura is a clinical research coordinator associate for the Stanford School of Medicine, department of Cancer Genetics and Genomics. She received her B.A. in anthropology and intensive sociology from the University of California Santa Cruz.
She is also the family health navigator for the Genetic Information and Family Testing (GIFT) Study. GIFT's mission is to help families beat cancer. It aims to save lives through education and communication about cancer risk and prevention in families. When someone learns they have a genetic mutation that increases their risk for cancer, it means their family members might also be at risk. For too long, the difficult job of talking about family cancer risk has fallen to the cancer patients alone. GIFT is here to make it easier for people to share this important information and give family members an easy way to get genetic testing to learn about their personal cancer risk. GIFT is an online program developed by cancer patients, family members, and doctors that offers a new way to, 1. Share life-saving information about family cancer risk and ways to lower that risk, 2.Connect interested family members to easy, at-home genetic testing. -
Aditi Risbud Bartl, Ph.D.
Director, IT Strategic Communications, CIO Office, UIT
Current Role at StanfordDirector, IT Strategic Communications
University IT -
Dan Riskin
Clinical Professor (Affiliated), Surgery - General Surgery
Staff, Surgery - General SurgeryBioDr. Riskin is a Clinical Professor of Surgery at Stanford University and a physician–entrepreneur focused on the application of artificial intelligence in healthcare. His work spans clinical practice, company building, and public policy, with a focus on using clinical data to improve care.
He has founded and led multiple healthcare technology companies applying artificial intelligence to clinical data, with products used by leading health systems, pharmaceutical companies, and insurers and influencing the care of millions of patients. He is the CEO of Verantos, a healthcare AI company focused on improving the reliability of real-world clinical data used in research and care.
Dr. Riskin has contributed to health policy in the United States and internationally, including Congressional testimony related to the 21st Century Cures Act and service on the U.S. Health Information Technology Advisory Committee (HITAC). His work has been featured in The Wall Street Journal and Forbes.
Dr. Riskin received his MD from Boston University, completed residency in surgery at UCLA, and fellowship training in critical care and acute care surgery at Stanford University. He is board-certified in surgery, critical care, palliative care, and clinical informatics. He also holds an MBA from the Massachusetts Institute of Technology and was a Stanford Biodesign Innovation Fellow. -
Jessica Riskin
Frances and Charles Field Professor of History
BioJessica Riskin received her B.A. from Harvard University and her Ph.D. from the University of California at Berkeley. She taught at MIT before coming to Stanford, and has also taught at Iowa State University and at Sciences Po, Paris. Her research interests include early modern science, politics and culture and the history of scientific explanation.
Riskin is the author of Science in the Age of Sensibility: The Sentimental Empiricists of the French Enlightenment (2002), which won the American Historical Association's J. Russell Major Prize for best book in English on any aspect of French history, and the editor of Genesis Redux: Essays in the History and Philosophy of Artificial Life (2007) and, with Mario Biagioli, of Nature Engaged: Science in Practice from the Renaissance to the Present (2012). She is also the author of The Restless Clock: A History of the Centuries-Long Debate over What Makes Living Things Tick (2016), which won the 2021 Patrick Suppes Prize in the History of Science from the American Philosophical Society.
